Environmental stress (e.g. aniso-osmolarity and UV light), hypoxia/reoxygenation, and reactive oxygen species activate intracellular signaling cascades such as the "stress-responsive" mitogen-activated protein kinases and nuclear factor B. We have recently shown that the Janus tyrosine kinase/signal transducer and activator of transcription (Jak/STAT) pathway is ligand-independently activated by hyperosmotic shock. In the present study, we show that besides STAT1 also the tyrosine phosphatase SHP2 became tyrosine-phosphorylated upon hyperosmolarity. SB 202190 and SB 203580 (specific inhibitors of p38) inhibited both STAT activation and tyrosine phosphorylation of SHP2 induced by hyperosmotic stress. Overexpression of wild-type p38 mitogen-activated protein kinase and its upstream activator mitogen-activated protein kinase kinase 6 (MKK6) resulted in an enhanced STAT1 tyrosine phosphorylation upon osmotic shock. Accordingly, overexpression of dominant negative mutants of p38 and MKK6 largely decreased hyperosmotic STAT1 activation and tyrosine phosphorylation of SHP2. Furthermore, we provide evidence that a genistein-sensitive tyrosine kinase different from Jak1 is involved in stress-activation of STAT1 and tyrosine phosphorylation of SHP2. These results strongly suggest that hyperosmotic shock activates STAT1 and SHP2 via p38 and its upstream activator MKK6.
cellular processes such as proliferation, differentiation, and apoptosis. In mammals, MAP kinases are divided into at least three subfamilies: the "classical" extracellular signal-regulated kinases (extracellular signal-regulated kinases 1 and 2), the stress-activated protein kinases/c-Jun N-terminal kinases (JNK), and the cytokine-suppressive anti-inflammatory drugbinding protein/p38. Whereas extracellular signal-regulated kinase-type MAP kinases are preferentially activated by a variety of cell growth and differentiation stimuli and by hypoosmolarity, JNK and p38 are primarily activated by various environmental stresses (for reviews, see Refs. 1-3). p38 has substantial similarity to the S. cerevisiae HOG1 kinase, a yeast MAP kinase required for cellular osmoregulation (4) . Like HOG1, p38 is activated in response to changes in environmental osmolarity. It further appears to be involved in the signal transduction of lipopolysaccharide and inflammatory mediators such as tumor necrosis factor ␣ and IL-1 (4 -6). The major upstream activators of p38 are the recently discovered dual specific MAP kinase kinases (MKKs) MKK3 and MKK6, while the related MKK4 activates both p38 and JNK (7, 8) .
Another key signaling system involved in the signal transduction of numerous interleukins and the interferons as well as a number of growth and differentiation factors is the Janus kinase (Jak)/signal transducer and activator of transcription (STAT) pathway. The binding of mediators to their respective receptors activates tyrosine kinases of the Jak family, followed by tyrosine phosphorylation, dimerization, and nuclear translocation of STAT factors (for a review, see Ref. 9) . At least upon IL-6 signaling, also the tyrosine phosphatase SHP2 is subject to phosphorylation, although its specific function is still unclear. It has been reported that SHP2 negatively regulates IL-6-induced gene transcription (10, 11) . Further, there is evidence that it acts as an adaptor linking the Jak/STAT pathway to the MAP kinase pathway via Grb2 (12) .
Recently, we have shown that in a number of primary cells and cell lines, hyperosmotic shock results in the tyrosine phosphorylation of Jak1, Jak2, and Tyk2 and in the activation of mainly STAT1 and/or STAT3. Furthermore, an important role of Jak1 in the activation of STAT by hypertonicity was demonstrated (13) .
In this study, we explored the possible interactions between the Jak/STAT and the p38 kinase pathways under hyperosmotic conditions. We show that, apart from Jaks and STAT factors, the tyrosine phosphatase SHP2 becomes also phosphorylated upon hyperosmotic shock. We could demonstrate that p38 and its upstream activator MKK6 participate in the activation of STAT1 and tyrosine phosphorylation of SHP2 by hyperosmotic shock. Further evidence is given that a proteintyrosine kinase different from Jak1 is required for hyperosmotic STAT activation.
EXPERIMENTAL PROCEDURES
Materials-Restriction enzymes were purchased from Roche Molecular Biochemicals (Mannheim, Germany). Oligonucleotides were obtained from MWG Biotech (Ebersberg, Germany), and SB 203580 (14) and SB 202190 (5) were from Calbiochem (Bad Soden, Germany). Dulbecco's modified Eagle's medium (DMEM) was from Life Technologies, Inc. (Eggstein, Germany), and fetal calf serum was from Seromed (Berlin, Germany). Recombinant human IL-6 and soluble IL-6 receptor gp80 were prepared as described (15, 16) . DEAE-dextran and chloroquine were purchased from Sigma (Deisenhofen, Germany).
Cell Culture and Stimulation of Cells-COS-7 cells were grown in DMEM at 5% CO 2 in a water-saturated atmosphere. DMEM was supplemented with 10% fetal calf serum, streptomycin (100 mg/liter), and penicillin (60 mg/liter). Medium was changed and adjusted to 6 ml 16 h before experiments were carried out.
Cells grown in a 100-mm dish to about 80% confluence were stimulated with sorbitol by adding 2 ml of 2.4 M sorbitol (final concentration of 600 mM sorbitol) dissolved in cell culture medium. Controls received the appropriate volume of cell culture medium. SB 202190 and SB 203580 were dissolved in Me 2 SO and added to the culture medium 20 -40 min before stimulation at concentrations as indicated in the figure legends. Nuclear extracts were prepared as described by Andrews and Faller (17) . Protein concentrations were determined with a Bio-Rad protein assay.
DNA Constructs and Transfection Procedures-cDNAs for p38 wildtype and p38(AF) mutant tagged with the FLAG epitope (18) were cloned into the KRSPA expression vector as described in Flory et al. (19) . PCDNA3-FLAG-MKK6 wild-type and mutants were a kind gift from Dr. R. Davis (Worcester, MA). Transfection of COS-7 cells was performed using 10 -20 g of DNA, according to the DEAE-dextran method described elsewhere (20) , with slight modifications. Briefly, COS-7 cells were grown in 75-cm 2 flasks to approximately 90% confluence. 10 -20 g of cDNA were mixed with serum-free DMEM, and DEAE-dextran and chloroquine were added to a final concentration of 0.08 mM and 0.4 mg/ml, respectively. Cells were incubated for 60 -80 min at 37°C under exclusion of gas exchange and then washed with phosphate-buffered saline, shocked with 10% Me 2 SO diluted in phosphate-buffered saline for 1 min, and washed again with phosphatebuffered saline. Incubation was continued in DMEM containing 10% serum for at least 16 h; cells were then split and cultured for another 24 h.
Electrophoretic Mobility Shift Assay (EMSA)-EMSAs were performed as described previously (21) using a double-stranded 32 P-labeled mutated m67SIE oligonucleotide from the c-fos promotor (m67SIE, 5Ј-GAT CCG GGA GGG ATT TAC GGG GAA ATG CTG-3Ј) (22) . The protein-DNA complexes were separated on a 4.5% polyacrylamide gel containing 7.5% glycerol in 0.25-fold TBE (20 mM Tris, 20 mM boric acid, 0.5 mM EDTA) at 20 V/cm for 4 h. Gels were fixed in 10% methanol, 10% acetic acid, and 80% water for 1 h, dried, and autoradiographed.
Immunoprecipitation-Cells were washed twice with phosphatebuffered saline and solubilized in 1 ml of lysis buffer (0.5% Nonidet P-40, 50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 mM NaF, 1 mM EDTA, 20 mM glycerophosphate, 1 mM Na 3 VO 4 , 0.25 mM phenylmethylsulfonyl fluoride, 5 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin, and 15% glycerol) for 30 min at 4°C. Insoluble material was removed by centrifugation, and the cell lysate was incubated with specific antibodies at 4°C for a minimum of 2 h. The immune complexes were bound to protein A-Sepharose (5 mg/ml in lysis buffer) for 1 h at 4°C. After centrifugation, the Sepharose beads were washed three times with wash buffer (0.05% Nonidet P-40, 50 mM Tris/HCl, pH 7.4, 100 mM NaCl, 1 mM NaF, 1 mM EDTA, 20 mM glycerophosphate, 1 mM Na 3 VO 4 , and 15% glycerol). The samples were boiled in gel electrophoresis sample buffer, and the precipitated proteins were separated on an SDSpolyacrylamide (7.5%) gel. The following antibodies were used: antiJak1 rabbit polyclonal antibodies (kindly provided by Dr. Ziemiecki, Bern, Laboratory for Clinical and Experimental Cancer Research) and anti-SHP2 rabbit polyclonal antibody from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Immunoblotting and Immunodetection-The electrophoretically separated proteins were transferred onto polyvinylidene difluoride (PVDF) membranes by the semidry Western blotting method. Nonspecific binding was blocked with 10% bovine serum albumin in TBS-N (20 mM Tris/HCl, pH 7.4, 137 mM NaCl, and 0.1% Nonidet P-40) for 15 min. The blots were incubated with primary antibodies at a 1:1000 dilution in TBS-N for 1 h. After extensive rinsing with TBS-N, blots were incubated with secondary antibodies, goat anti-rabbit IgG, or goat antimouse IgG conjugated to horseradish peroxidase for 1 h. After further rinsing in TBS-N, the immunoblots were developed with the ECL system (Amersham Pharmacia Biotech) following the manufacturer's instructions. The following primary antibodies were used: anti-phosphotyrosine mouse monoclonal antibody (4G10; Upstate Biotechnology, Inc.); anti-Jak1 rabbit polyclonal antibodies; anti-SHP2 rabbit polyclonal antibody (Santa Cruz Biotechnology); phosphotyrosine-specific STAT1 (Tyr 701 ) rabbit polyclonal antibody (New England Biolabs); phosphoserine-specific STAT1 (Ser 727 ) rabbit polyclonal antibody (Upstate Biotechnology); anti-p38 rabbit polyclonal antibody (Santa Cruz Biotechnology); and anti-active p38 rabbit polyclonal antibody (Promega).
p38 in Vitro Kinase Assay-Cells were lysed in a modified lysis buffer (0.5% Nonidet P-40, 50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 20 mM ␤-glycerophosphate, 1 mM NaF, 1 mM EDTA, 1 mM Na 3 VO 4 , 5 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin, 1 mM Pefabloc, and 15% glycerol), and immunoprecipitation was performed as described above using p38 rabbit polyclonal antibody (Upstate Biotechnology). The beads were washed twice with wash buffer (0.05% Nonidet P-40, 50 mM Tris/HCl, pH 7.4, 100 mM NaCl, 20 mM ␤-glycerophosphate, 1 mM NaF, 1 mM EDTA, 1 mM Na 3 VO 4 , and 15% glycerol) and twice with kinase assay buffer A (20 mM Tris/HCl, pH 7.4, 20 mM ␤-glycerophosphate, 20 mM MgCl 2 , and 1 mM Na 3 VO 4 ). Immunoprecipitates were mixed with 400 ng of purified MAP kinase-activated protein kinase 2 (Upstate Biotechnology) and 5 Ci of [␥-
32 P]ATP in 20 l of kinase assay buffer B (20 mM Tris/HCl, pH 7.4, 20 mM ␤-glycerophosphate, 20 mM MgCl 2 , 2 mM dithiothreitol, and 1 mM Na 3 VO 4 ). Incubation was at 30°C for 30 min. The reaction was terminated by the addition of gel electrophoresis sample buffer and boiling. The samples were resolved by 10% SDS-PAGE and subjected to autoradiography.
RESULTS

p38 and Its Upstream Activator MKK6 Are Required for
Hyperosmotic STAT Activation-Our recent finding that hyperosmolarity leads to a rapid and ligand-independent activation of the Jak/STAT pathway (13) and the well known fact that an osmotic shock also results in an activation of the p38 MAP kinase (4) raise the question of whether these two processes are connected. As shown in Fig. 1 , upon hyperosmotic stress, p38 activity in COS-7 cells as determined by an activation-dependent antibody and by an in vitro kinase assay using MAP kinaseactivated protein kinase 2 as a substrate parallels activation of STAT1 assessed by an EMSA with an oligonucleotide from the FIG. 1. p38 activity parallels the activation of STAT1 in COS-7 cells upon hypertonic treatment. COS-7 cells were treated with 600 mM sorbitol for the times indicated. Cell lysates were prepared, and after immunoprecipitation with anti-p38 antibodies an in vitro kinase assay with MAP kinase-activated protein kinase-2 (MAPKAP-K2) as a substrate was performed as described under "Experimental Procedures" (third panel). 50 g of protein from the same lysate were separated by 10% SDS-PAGE and blotted onto a PVDF membrane. Membranes were incubated with polyclonal antibodies specifically raised against the activated form of p38 (top panel). Blots were stripped and reprobed with anti-p38 antibodies (second panel). For the determination of STAT1 activation, cells were harvested, and nuclear extracts were prepared and analyzed as described under "Experimental Procedures." 5 g of nuclear extracts were mixed with a 32 P-labeled oligonucleotide (mutated SIE probe of the c-fos promoter 5Ј-GAT CCG GGA GGG ATT TAC GGG GAA ATG CTG-3Ј) and EMSAs were performed. The DNA-protein complexes formed were separated from the free probe by electrophoresis on a native 4.5% gel (lower panel).
p38/MKK6 Activate STAT1 upon Hyperosmotic Shockc-fos promotor (mutated SIE probe (22)). p38 and STAT remained activated over at least 3 h. We next studied the influence of SB 202190 or SB 203580 (specific inhibitors of p38) on hyperosmotic STAT activation. Inhibition of the p38 kinase almost completely abolished hyperosmotic STAT1 activation as assessed by an EMSA and anti-phosphotyrosine blotting (Fig.  2) . This inhibition was already detectable at concentrations of 1 M and maximal at concentrations higher than 5 M (Fig. 2A) . Interestingly, IL-6-induced STAT activation in COS-7 cells was not affected by p38 inhibitors (Fig. 2B, two right lanes) . These data suggest that the p38 MAP kinase might be involved in hyperosmotic STAT activation.
This notion was further substantiated by overexpression of wild type and kinase-deficient mutants of p38 and of its upstream activator MKK6 in COS-7 cells. In the inactive MKK6(A) mutant, the conserved lysine in the ATP binding site is replaced by alanine (23) , whereas the inactive p38 kinase was generated by replacement of two activating phosphorylation sites with alanine and phenylalanine, respectively (p38(AF)) (18) . Transient overexpression of wild-type p38 (Fig.  3A) and MKK6 (Fig. 3B ) resulted in an enhanced tyrosine phosphorylation and binding to a cognate DNA probe of STAT1 upon hyperosmotic stress. In contrast, overexpression of the dominant-negative mutants p38(AF) (Fig. 4A ) and MKK6(A) (Fig. 4B ) markedly suppressed the activation of STAT1 by hyperosmolarity. A faster migrating band below STAT1 is recognized by both a STAT1-and a phosphotyrosine 701-STAT1-specific antiserum, suggesting that it might represent STAT1␤ (former p84 (24)). However, although this protein is apparently constitutively phosphorylated, it does not bind to the SIE probe in an EMSA. Therefore, it could also represent an unrelated polypeptide that is unspecifically recognized by the antisera.
Since the p38 MAP kinase is a serine/threonine kinase, we asked whether p38 might affect the serine phosphorylation of STAT1 at serine 727, which lies within a putative MAP kinase consensus motif (25, 26) , and thereby indirectly favor its tyrosine phosphorylation. As depicted in Fig. 5 phosphorylation at serine 727 of STAT1 slightly increased under hyperosmotic conditions with a time course similar to tyrosine phosphorylation. However, overexpression of wild type or kinase-deficient forms of p38 or MKK6 did not significantly affect phosphorylation of STAT1 at serine 727. These data indicate that although activation of the MKK6/p38 pathway is essential for activation of STAT1 by hyperosmotic shock, it is independent of phosphorylation at serine 727.
Protein-tyrosine Kinase Activity Independent of Jak1 Is Required for Hyperosmotic STAT Activation-The fact that p38 is a serine/threonine protein kinase necessitates another regulatory step leading to the tyrosine phosphorylation of STAT1. As shown in Fig. 6A , hyperosmotic STAT activation is dose-dependently decreased when cells were treated with genistein, an unspecific inhibitor of protein-tyrosine kinases, before exposure to hyperosmotic stress. STAT activation was not affected by equal concentrations of daidzein, the inactive analog of genistein, demonstrating that the inhibitory effect of genistein is specific (Fig. 6B) . This indicates that a protein-tyrosine kinase activity is required for activation of STAT1 by hypertonicity. Studies on Jak1-deficient U4A cell lines suggested that Jak1 is important for the hyperosmotic STAT activation (13) . Therefore, it appeared likely that the genistein-sensitive tyrosine kinase necessary for hyperosmotic STAT activation is Jak1, possibly regulated by p38. However, as shown in Fig. 7A , ) with SB 202190 at the concentrations indicated, COS-7 cells were treated with 600 mM sorbitol or 200 units/ml IL-6 plus 0.5 g/ml soluble interleukin-6 receptor gp80 (sgp80) for 20 min. Cells were harvested, and nuclear extracts were prepared. EMSAs were performed as described in the legend to Fig. 1 (lower panel) . For immunoblots, 40 g of proteins were separated by 7.5% SDS-PAGE. Immunoblots were developed using specific antibodies directed against STAT1 phosphorylated at tyrosine 701 (top panel) and as loading control reprobed with antibodies specific for STAT1 (second panel).
FIG. 3. STAT factor activation after hyperosmotic shock is dependent on p38 kinase and its upstream activator MKK6.
A, COS-7 cells were transfected with either the empty KRSPA (control) vector or KRSPA-FLAG-p38 wild type (p38 wild-type). B, COS-7 cells were transfected with either the empty pcDNA3 (control) vector or with the pcDNA3-FLAG-MKK6 wild type (MKK6 wild-type). After 2 days, cells were treated with 600 mM sorbitol for the times indicated, after which cells were harvested, and nuclear extracts were prepared as described in the legend to Fig. 1 . For immunoblots, 40 g of proteins were separated by 7.5% SDS-PAGE. Immunoblots were developed using specific antibodies directed against STAT1 phosphorylated at tyrosine 701 (top panel) and as loading control reprobed with antibodies specific for STAT1 (second panel). 5 g of nuclear extracts were mixed with a 32 P-labeled oligonucleotide (mutated SIE probe of the c-fos promoter), and EMSAs were performed (lower panel).
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there was no effect of genistein on tyrosine phosphorylation of Jak1 induced by hyperosmolarity (Fig. 7A) . Furthermore, the p38 kinase inhibitors SB 203580 (Fig. 7A ) and SB 202190 (Fig.   7B ) did not markedly influence stress-induced tyrosine phosphorylation of Jak1. Since it is currently believed that the tyrosine phosphorylation of Jak1 is mainly due to autophosphorylation, these data indicate that Jak1 activity is neither responsible for the genistein-sensitive hyperosmotic STAT activation nor regulated by the p38 pathway.
Hyperosmotic Activation of the Tyrosine Phosphatase SHP2 Is Dependent on p38 and Protein-tyrosine Kinase Activity-STAT activation could be not only the result of increased tyrosine kinase activity but also the result of the inhibition of an inactivating tyrosine phosphatase. SHP2 is a tyrosine phosphatase that has been connected to the Jak/STAT pathway although its specific function remains to be elucidated. SHP2 is thought to be a gp130-associated adapter connecting the signal transducer to Grb2, thereby linking the Jak/STAT to the MAP kinase pathway (12) . Further, it has been reported that SHP2 negatively modulates IL-6-induced gene expression (10, 11). We therefore asked whether SHP2 plays a role in the hyperos- vector or with a FLAG-tagged kinase-deficient mutant of p38 (AF) (p38 dn). B, COS-7 cells were transfected with either the empty pcDNA3 (control) vector or with a FLAG-tagged kinase-deficient mutant of MKK6 (A) (MKK6 dn). After 2 days, cells were treated with 600 mM sorbitol for the times indicated, after which cells were harvested, and nuclear extracts were prepared as described in the legend to Fig. 1 . For immunoblots, 40 g of proteins were separated by 7.5% SDS-PAGE. Immunoblots were developed using specific antibodies directed against STAT1 phosphorylated at tyrosine 701 (top panel) and as loading control reprobed with antibodies specific for STAT1 (second panel). 5 g of nuclear extracts were mixed with a , COS-7 cells were treated with 600 mM sorbitol for 20 min. Cell lysates were prepared, and immunoprecipitation with anti-Jak1 antibody was performed as described under "Experimental Procedures." Precipitated proteins were separated by 7.5% SDS-PAGE, blotted onto a PVDF membrane, and analyzed with a specific anti-phosphotyrosine antibody (upper panel). Blots were stripped and reprobed with anti-Jak1 antibody to verify equal loading (lower panel).
p38/MKK6 Activate STAT1 upon Hyperosmotic Shockmotic STAT activation and if so whether it is regulated by the p38 MAP kinase and/or by genistein-sensitive tyrosine kinases, respectively. Fig. 8 shows that SHP2 becomes tyrosine-phosphorylated within 15 min upon hyperosmotic shock and that this phosphorylation persisted for at least 45 min. Inhibition of p38 by SB 202190 dose-dependently suppressed also tyrosine phosphorylation of SHP2 (Fig. 9A) . In addition, overexpression of a kinase-deficient mutant of p38 (Fig. 9B) or MKK6 (Fig. 9C ) inhibited tyrosine phosphorylation of SHP2, whereas overexpression of wild-type kinase had almost no effect. Inhibition of protein-tyrosine kinases by genistein decreased the hyperosmotically induced tyrosine phosphorylation of SHP2 (Fig. 9A) . Vogel et al. (27) have shown the extent of tyrosine phosphorylation of SHP2 to correspond to its phosphatase activity. Considering a regulatory role of SHP2 for the hyperosmotic STAT activation, phosphorylation of this phosphatase should behave contrary, not parallel to, STAT activation. Thus, it is most unlikely that inactivation of the tyrosine phosphatase SHP2 is responsible for STAT activation upon hyperosmolarity.
DISCUSSION
Activation of the p38 kinase cascade is known as one of the major events occurring after hyperosmotic shock (4) . Recently, we demonstrated that also the Jak/STAT pathway is activated by hyperosmolarity. Studies on Jak1-, Jak2-, and Tyk2-deficient cell lines suggested that Jak1 might be important for the hyperosmotic STAT activation (13) . Here we give evidence that tyrosine phosphorylation and activation of STAT1 in response to hyperosmotic treatment occurs at least in part via the MKK6/p38 pathway. This was shown by inhibition of the p38 MAP kinase using specific inhibitors and by overexpression of wild type or kinase-deficient mutants of p38 and MKK6. Our data further indicate that the interaction between MKK6/p38 and STAT1 does not involve Jak1, although protein-tyrosine kinase activity is required for hyperosmotic STAT activation.
It has been reported that the transactivating capability of STAT1 depends at least partially on the phosphorylation of serine 727, located within a potential MAP kinase consensus motif in the C-terminal transactivation domain (25, 26, 28, 29) . Furthermore, after bacterial infection or administration of lipopolysaccharide prior to IFN␥ treatment, phosphorylation of STAT1 at tyrosine 701 and at serine 727 occurred independently from each other, leading to an increased transcriptional response (30) . However, tyrosine-phosphorylated STAT1 was found to a larger extent to be also phosphorylated on serine 727 as compared with non-tyrosine-phosphorylated STAT1, indicating that serine phosphorylation of STAT1 possibly facilitates tyrosine phosphorylation (30) . Thus, one could speculate that p38 modulates tyrosine phosphorylation of STAT1 by phosphorylation of serine 727. However, another group recently presented in vitro and in vivo evidence that the extracellular signal-regulated kinase-type MAP kinases specifically phosphorylate STAT3 at serine 727 in response to growth factors negatively modulating STAT3 tyrosine phosphorylation (26) . Moreover, these authors could show that neither JNK1 nor p38 was able to phosphorylate STAT1 or STAT3 in vitro when immunoprecipitated from cell lysates prepared after stimulation with 600 mM sorbitol (26) . In correspondence to these observations, we found in this study that overexpression of wild type or kinase-deficient forms of p38 or MKK6 did not significantly affect phosphorylation of STAT1 at serine 727. Therefore, our data support the assumption that STAT1 is not a substrate of p38 in vivo Since p38 is a serine/threonine protein kinase and a direct action of p38 on STAT1 is unlikely, tyrosine phosphorylation and activation of STAT1 after hyperosmotic shock must occur indirectly. This could be either by activation of a tyrosine kinase controlled by serine-threonine phosphorylation or by inhibition of a tyrosine phosphatase negatively regulated by serine/threonine phosphorylation. A tyrosine phosphatase that has been frequently associated with the Jak/STAT pathway is SHP2 (also termed as PTP1D, Syp, or SH-PTP2). The functional implications of SHP2 for the signal transduction via the Jak/STAT pathway are largely unknown. It binds with its SH2 domain specifically to phosphorylated tyrosine 759 from the gp130 receptor subunit cytoplasmic domain, thereby linking gp130 via Grb2 to the MAP kinase pathway (12) . Further, previous work by Schaper et al. (10) and Kim et al. (11) showed that activation of SHP2 limits acute phase protein expression most likely via dephosphorylation of gp130, Jaks, or STATs. Here we show that upon hyperosmotic shock SHP2 becomes phosphorylated with a time course similar to STAT1 activation FIG. 8 . SHP2 becomes tyrosine phosphorylated upon hyperosmotic shock. COS-7 cells were treated with 600 mM sorbitol for the times indicated. Cell lysates were prepared, and immunoprecipitation with anti-SHP2 antibody was performed as described under "Experimental Procedures." Precipitated proteins were separated by 7.5% SDS-PAGE, blotted onto a PVDF membrane, and analyzed with a specific anti-phosphotyrosine antibody (upper panel). Blots were stripped and reprobed with anti-SHP2 antibody to verify equal loading (lower panel).
FIG. 9.
Stress induced tyrosine phosphorylation of SHP2 depends on p38 and MKK6 activity. A, after a 40-min pretreatment with SB 202190, genistein, or daidzein at the concentration indicated, COS-7 cells where treated with 600 mM sorbitol. B, COS-7 cells were transfected with either the empty KRSPA (Control) vector or with wild type (p38wt) or the kinase-deficient mutant of p38 (p38dn). After 2 days, cells were treated with 600 mM sorbitol for 20 min. C, COS-7 cells were transfected with either the empty pcDNA3 (Control) vector or with wild type (MKK6 wt) or with the kinase-deficient mutant MKK6 A (MKK6 dn). Cell lysates were prepared, and immunoprecipitation with anti-SHP2 antibody was performed as described under "Experimental Procedures." Precipitated proteins were separated by 7.5% SDS-PAGE, blotted onto a PVDF membrane, and analyzed with a specific antiphosphotyrosine antibody (upper panels). Blots were reprobed with anti-SHP2 antibody to verify equal loading (lower panels).
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and that this phosphorylation is regulated at least partially by MKK6/p38 and a genistein-sensitive tyrosine kinase. It is currently believed that the extent of tyrosine phosphorylation of SHP2 corresponds to its phosphatase activity (27) . Since we did not observe that the SHP2 tyrosine phosphorylation behaves in reverse to the tyrosine phosphorylation of STAT1, we assume that inhibition of phosphatase activity of SHP2 is probably not involved in the activation of STAT1 due to hyperosmotic stress.
Another phosphatase that was reported to negatively regulate STAT activation is MAP kinase phosphatase 1 (31) . This phosphatase belongs to a class of dual specific phosphatases inactivating extracellular signal-regulated kinase-type MAP kinases and JNK by dephosphorylation (32) (33) (34) . MAP kinase phosphatases are the products of immediate early genes whose mRNA is rapidly induced following such divergent stimuli as serum, epidermal growth factor, neural growth factor (32, 35), short wave UV light, and DNA-alkylating agents (34) . However, p38 has been suggested to induce transcription of MAP kinase phosphatase 1 upon hyperosmotic stress, since the hyperosmotic induction of MAP kinase phosphatase 1 mRNA can be blocked by p38 MAP kinase inhibition (36) . Since MAP kinase phosphatase 1 activity is only regulated on the level of transcription (32) , its induction by p38 makes it an unlikely candidate for the hyperosmotic STAT activation via p38.
Another possible mechanism for the MKK6/p38-mediated STAT activation by hyperosmolarity is via activation of a protein-tyrosine kinase controlled by serine/threonine phosphorylation by p38. We report here that genistein, an unspecific inhibitor of protein-tyrosine kinases inhibits activation of STAT1 and tyrosine phosphorylation of SHP2 upon hyperosmotic shock, whereas tyrosine phosphorylation of Jak1 is not affected. This suggests that a genistein-sensitive tyrosine kinase different from Jak1 is required for hyperosmotic STAT activation and tyrosine phosphorylation of SHP2. We therefore consider it to be more likely that a tyrosine kinase, not a tyrosine phosphatase, is the regulatory step between MKK6/ p38 and STAT1 activation upon hypertonicity. In this respect, it is interesting to note that depending on the stress employed, activation of JNK can be either the result of an increased phosphorylation (anisomycin, UV irradiation, and osmotic stress) or an inhibition of a JNK phosphatase (heat shock, oxidative stress, and ethanol (37) ). If this model of JNK regulation is also valid for the activation of STAT1 upon hyperosmotic shock, it would support our notion that a tyrosine kinase is involved. Identification of this putative tyrosine kinase representing the link between hyperosmotic STAT activation and p38 will be our future goal.
